CA2285852A1 - Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline - Google Patents

Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline Download PDF

Info

Publication number
CA2285852A1
CA2285852A1 CA 2285852 CA2285852A CA2285852A1 CA 2285852 A1 CA2285852 A1 CA 2285852A1 CA 2285852 CA2285852 CA 2285852 CA 2285852 A CA2285852 A CA 2285852A CA 2285852 A1 CA2285852 A1 CA 2285852A1
Authority
CA
Canada
Prior art keywords
lisinopril
microcrystalline cellulose
disodium
pharmaceutical tablet
tablet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2285852
Other languages
English (en)
Other versions
CA2285852C (fr
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2285852 priority Critical patent/CA2285852C/fr
Publication of CA2285852A1 publication Critical patent/CA2285852A1/fr
Application granted granted Critical
Publication of CA2285852C publication Critical patent/CA2285852C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
CA 2285852 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline Expired - Fee Related CA2285852C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2285852 CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2285852 CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Publications (2)

Publication Number Publication Date
CA2285852A1 true CA2285852A1 (fr) 2000-01-04
CA2285852C CA2285852C (fr) 2001-04-03

Family

ID=4164363

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2285852 Expired - Fee Related CA2285852C (fr) 1999-10-26 1999-10-26 Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline

Country Status (1)

Country Link
CA (1) CA2285852C (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458769B1 (en) 2001-06-25 2002-10-01 Astrazeneca Ab Amorphous compound
US6462174B1 (en) 2001-06-25 2002-10-08 Astrazeneca Ab Amorphous compound
US6627760B1 (en) 2001-06-25 2003-09-30 Astrazeneca Ab Amorphous compound

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458769B1 (en) 2001-06-25 2002-10-01 Astrazeneca Ab Amorphous compound
US6462174B1 (en) 2001-06-25 2002-10-08 Astrazeneca Ab Amorphous compound
US6627760B1 (en) 2001-06-25 2003-09-30 Astrazeneca Ab Amorphous compound

Also Published As

Publication number Publication date
CA2285852C (fr) 2001-04-03

Similar Documents

Publication Publication Date Title
ZA200110217B (en) Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application.
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
AU3218299A (en) Press coated, pulsatile drug delivery system suitable for oral administration
HUP0202100A3 (en) Novel quinuclidine derivatives, process for their preparation and medicinal compositions containing the same
AU3574500A (en) Rapidly disintegrable tablet for oral administration
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
HUP9603494A3 (en) Hydroxycarboxamide derivatives, pharmaceutical compositions containing them, process for the preparation thereof
ZA200003702B (en) Beta-carboline compounds, a process for their preparation and pharmaceutical compositions containing them.
CA2622805A1 (fr) Comprimes comprenant du valsartan
WO2001032181A3 (fr) Compositions pharmaceutiques contenant un medicament antibiotique de fluoroquinolone et une gomme xanthan
AU6611396A (en) New oxazolidinone derivatives, processes for the production thereof and pharmaceutical agents containing these compounds
CA2347195A1 (fr) Compositions pharmaceutiques orales contenant buprenorphine
HRPK20010706B1 (en) Tolperison-containing, pharmaceutical preparation for oral administration
NZ515339A (en) Use of macrolide compounds for the treatment of dry eye
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
TW200716550A (en) Pharmaceutical composition comprising ritonavir
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
WO2000006606A3 (fr) Derives d'erythromycine ayant une activite antibiotique
HUP0101234A3 (en) Betha-carboline derivatives, process for their preparation and pharmaceutical compositions thereof
CA2209868A1 (fr) Compositions pharmaceutiques a base de cefuroxime axetil
CA2285852A1 (fr) Comprime pharmaceutique comprenant du lisinoprile disodique et de la cellulose microcristalline
HUP0200928A2 (hu) Pirido-tieno-diazepinek, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
HUP0200343A3 (en) Phenylalaninol derivatives, process for their preparation, pharmaceutical compositions containing them and their use
EP1059304A4 (fr) Nouveaux derives de polysaccharide, leur procede de production, et compositions medicinales contenant ces nouveaux derives comme principe actif
HUP0001712A2 (en) 2,3-methano-amino acid derivatives, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed